数据链接：
官方服务：
资源简介：
History of ART in children with drug resistance.
应用场景：
创建时间：
2021-03-18
相关数据集
Table_1_Effectiveness and Safety of Atazanavir Use for the Treatment of Children and Adolescents Living With HIV: A Systematic Review.DOCX
BackgroundAtazanavir/ritonavir is recommended as a preferred second-line antiretroviral regimen in children older than 3 months, alternatively to lopinavir/ritonavir. We performed a systematic review
NIAID Data Ecosystem90
Factors associated with virological failure (HIV-RNA >1000 copies/ml) in children who achieved initial virological suppression.
3TC, lamivudine; aHR, adjusted hazard ratio; AZT, zidovudine; CI, confidence interval; NNRTI, non-nucleoside reverse transcriptase inhibitor; NRTI, nucleoside reverse transcriptase inhibitor; NVP, nev
Figshare2015-12-02 更新50
Log-rank test for equality of survivor functions among under- five children on ART treatment in public hospitals of Addis Ababa, Ethiopia, 2022.
Log-rank test for equality of survivor functions among under- five children on ART treatment in public hospitals of Addis Ababa, Ethiopia, 2022.
NIAID Data Ecosystem30
Data_Sheet_1_Viruses Previously Identified in Brazil as Belonging to HIV-1 CRF72_BF1 Represent Two Closely Related Circulating Recombinant Forms, One of Which, Designated CRF122_BF1, Is Also Circulating in Spain.PDF
Circulating recombinant forms (CRFs) are important components of the HIV-1 pandemic. Those derived from recombination between subtype B and subsubtype F1, with 18 reported, most of them of South Ameri
NIAID Data Ecosystem60
Survival Outcomes in a Pediatric Antiretroviral Treatment Cohort in Southern Malawi
Survival Outcomes in a Pediatric Antiretroviral Treatment Cohort in Southern Malawi
Global Health Data Exchange ()40
